CNS 1: Novel Approaches in Brain Metastases
Michael Yu, MD, MS, FASTRO (Session Moderator) 
2:30 - 3:45 p.m.
Room 152

146 - Early Detection of Metastatic Progression by Circulating Tumor DNA in PAtients Undergoing Bladder-Preserving Trimodality Therapy
Dekuang 'DK' Zhao, DO, PhD
4:45 - 4:55 p.m.
Room 24

SS 09 - Head and Neck 1: Highest-Rated Abstracts for Virally-Mediated Head and Neck Cancer
Jimmy Caudell, MD, PhD (Session Moderator)
4:45 - 6:00 p.m.
Room 305/306/309

163 - Real World Validation of a Head and Neck Specific Patient-Reported Outcome CTCAE Measure in a Radiation Oncology Clinic
Niema Razavian, MD
5:35 - 5:45 p.m. 
Room 314

2041 - Hypofractionated Online Adaptive Radiotherapy for a Personalized Approach to Muscle Invasive Bladder Cancer
Celina Chiodo, MD
2:30 - 4:00 p.m.
Hall F

2133 - Evaluating an Algorithm for CBCT Correction for Adaptive Planning
Kujtim Latifi, PhD
2:30 - 4:00 p.m.
Hall F

2460 - Balancing Quality of Life Considerations and Efficacy of Stereotactic Body Radiotherapy in Patients with Interstitial Lung Disease
Simran Polce, MD
4:45 - 6:00 p.m.
Hall F

2483 - Enhancing Adverse Event Monitoring in Prostate Cancer Care with Large Language Models
Monique Shotande, PhD
4:45 - 6:00 p.m.
Hall F

Real-World Use of Nivolumab plus Relatlimab in the Multi-Modal Management of Melanoma Brain Metastases
Vaseem Khatri, MD
8:00 - 9:00 a.m.
Hall F

User Experience with Artificial Intelligence-Generated Research Education Podcast Series
John Peterson, MD
8:00 - 9:00 a.m.
Hall F

Novel Fractionation and Radiobiological Techniques with Photon Therapy
Arash Naghavi, MD, MS
3:17 - 3:32 p.m. 
Room 314

EDU 37 - Integrating Radiation Therapy with Novel Immunotherapies in the Management of Brain Metastases and Leptomeningeal Disease
Kamran Ahmed, MD (Session Moderator)
8:00 - 9:00 a.m. 
Room 22/23

Vaccine Strategies in the Management of Leptomeningeal Disease
Peter Forsyth, MD
8:17 - 8:32 a.m. 
Room 22/23

Case 3: Refractory CNS Lymphoma - Primary or Secondary, Who Completed Bridging Radiotherapy to CAR T-cell Therapy
Nicholas Figura, MD
1:32 - 1:47 p.m. 
Room 160

Clinical Outcomes for Extracranial Oligometastatic Renal Cell Carcinoma Treated with Stereotactic Body Radiotherapy - Institutional Experience
Justyn Nakashima, DO
12:45 - 2:00 p.m. 
Hall F

Inpatient Radiotherapy: Insights for Hemostasis Consults
Simran Polce, MD
2:30 - 3:45 p.m.
Hall F